Mazdutide (10 mg Vial)
Mazdutide (10 mg Vial) is supplied as a lyophilized vial for laboratory research use. This page covers reconstitution volume, the resulting concentration, U-100 syringe equivalents and storage handling.
CAT No:
CAS No:
Synonyms/Alias:Mazdutide
M.F/Formula:
M.W/Mr.:
Purity:Specification by inquiry
- Sequence, purity and scale confirmation
- CoA and technical documentation requests
- API, research and cosmetic peptide options
- Distributor and institution quotation support
Mazdutide (10 mg Vial) is supplied as a lyophilized vial for laboratory research use. This page covers reconstitution volume, the resulting concentration, U-100 syringe equivalents and storage handling.
Quickstart
Reconstitute: Add 3.0 mL bacteriostatic water → ~ 3.33 mg/mL concentration (standard protocol).
Typical weekly range: 2.5–5 mg once weekly with gradual titration.
Easy measuring: At 3.33 mg/mL, 1 unit = 0.01 mL ≈ 33.3 mcg on a U‑100 insulin syringe.
Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles. [7]
Notes
Practical considerations for safe and effective administration. Use a new sterile insulin syringe for each weekly injection; dispose in a proper sharps container. [9] Rotate injection sites weekly (abdomen, thighs, upper arms) to minimize local irritation and lipoatrophy. [8] [10] For doses requiring >3 mL volume, split into two separate injections at different sites for comfort and absorption. Allow reconstituted vials to reach room temperature before withdrawing dose to reduce viscosity. Document dose, injection site, and any side effects to track response and optimize protocol.
Single peptide protocol reference : Available for related research, development or formulation inquiry workflows.: Available for related research, development or formulation inquiry workflows.
Reconstitution and handling reference : Available for related research, development or formulation inquiry workflows.: Available for related research, development or formulation inquiry workflows.
Research-use documentation inquiry : Available for related research, development or formulation inquiry workflows.: Available for related research, development or formulation inquiry workflows.
Peptide Vials (Mazdutide, 10 mg each): 8 weeks ≈ 3 vials (Weeks 1–4: 10 mg total = 1 vial; Weeks 5–8: 20 mg total = 2 vials)
12 weeks ≈ 5 vials (Weeks 1–4: 10 mg = 1 vial; Weeks 5–12: 40 mg = 4 vials)
16 weeks ≈ 7 vials (Weeks 1–4: 10 mg = 1 vial; Weeks 5–16: 60 mg = 6 vials)
Insulin Syringes (U‑100, 1 mL or 3 mL capacity): Per week: 1 syringe (once‑weekly dosing)
8 weeks: 8 syringes
12 weeks: 12 syringes
16 weeks: 16 syringes
Bacteriostatic Water (10 mL bottles): Use 3.0 mL per vial for standard reconstitution. 8 weeks (3 vials): 9 mL → 1 × 10 mL bottle
12 weeks (5 vials): 15 mL → 2 × 10 mL bottles
16 weeks (7 vials): 21 mL → 3 × 10 mL bottles
Alcohol Swabs: One for the vial stopper + one for the injection site each week. Per week: 2 swabs
8 weeks: 16 swabs → recommend 1 × 100‑count box
12 weeks: 24 swabs → recommend 1 × 100‑count box
16 weeks: 32 swabs → recommend 1 × 100‑count box
Send product, purity, quantity, destination and documentation requirements. Our team will follow up through online consultation or email.
WhatsApp: +852 52102460 +1 4422847013
Address: Huangpu District, Guangzhou, China